SANGAMO THERAPEUTICS, INC. Cash and Restricted Cash
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Cash and Restricted Cash of $27.59 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-14
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.59M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.95M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.53M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.84M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-03-31 | $27.59M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $20.95M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $30.53M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $39.84M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $26.68M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $43.42M 10-Q · filed 2026-05-14 |
| 2024-09-30 | $40.70M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $27.79M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $55.33M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $46.70M 10-K · filed 2026-03-30 |
| 2023-09-30 | $58.01M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $68.33M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $79.74M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $101.94M 10-K · filed 2025-03-17 |
| 2022-09-30 | $96.07M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $119.20M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $121.76M 10-Q · filed 2023-05-08 |
| 2021-12-31 | $180.37M 10-K · filed 2024-03-13 |
| 2021-09-30 | $178.45M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $171.38M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $124.47M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $132.83M 10-K · filed 2024-03-13 |
| 2020-09-30 | $260.89M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $468.94M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $87.25M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $81.93M 10-K · filed 2023-02-23 |
| 2019-09-30 | $117.79M 10-Q · filed 2020-11-04 |
| 2019-06-30 | $172.72M 10-Q · filed 2020-08-05 |
| 2019-03-31 | $84.47M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $143.92M 10-K · filed 2022-02-24 |
| 2018-09-30 | $119.24M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $62.91M 10-Q · filed 2019-08-07 |
| 2018-03-31 | $34.21M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $53.33M 10-K · filed 2021-02-24 |
| 2017-09-30 | $29.89M 10-Q · filed 2018-11-08 |
| 2017-03-31 | $18.49M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $22.06M 10-K · filed 2020-02-28 |